Search

everythinglearnresearchcommunity

for

Search:↓

Targeting EGFR may help reduce hair loss from chemotherapy.

Compounds from Alpinia zerumbet may help with hair regrowth and cancer treatment by targeting PAK1.

Hair follicles and deer antlers regenerate similarly through stem cells and are influenced by hormones and growth factors.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

Two different mutations in the vitamin D receptor gene cause different symptoms and responses to treatment in Lebanese patients with hereditary rickets.

No single treatment effectively cures hirsutism, and evidence for herbal remedies is weak.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Skin problems like psoriasis and systemic sclerosis can increase the risk of heart disease, so doctors should watch for heart risks in patients with these conditions.

Dutasteride is more effective than finasteride for hair loss treatment.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

There are many ways to treat Polycystic Ovary Syndrome, including lifestyle changes, surgery, and various medications, but more research is needed for better treatments.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

The medicine Cyclosporin A might cause excessive hair growth by reducing a protein that controls hair growth.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Certain gene variants can influence acne risk and severity.

Chemotherapy-induced hair loss is partly due to decreased laminin-511 and increased laminin-332.

Two rare genetic diseases cause severe rickets in children due to defects in vitamin D metabolism.

Cannabinoids may help treat various skin conditions.

S100A6 protein is linked to disease progression, especially in cancers.

The guideline provides recommendations for managing alopecia areata effectively.

Fetal ovaries produce different hormones than adult ovaries, and endocrine-disrupting chemicals may affect this process.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

PCL nanoscaffold-based liver spheroids are effective for drug screening and studying liver toxicity.

Wound healing can help prevent hair loss from chemotherapy in young rats by increasing interleukin-1β signaling.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

Ketoconazole shampoo may help reduce hair loss and improve hair health.

Advancements in understanding, diagnosing, and managing congenital adrenal hyperplasia have improved treatment and long-term outcomes.